phil nadeau: Live & Latest News Updates : Vimarsana.com

Dynavax Technologies (DVAX) Q1 2024 Earnings Call Transcript

Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript

VRTX earnings call for the period ending March 31, 2024.

Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2024 Earnings Call Transcript

Operator: Hello. Welcome to Vir Biotechnology’s First Quarter 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.

Neurocrine Biosciences' Huntington's disease drug gets FDA approval

By Sruthi Narasimha Chari (Reuters) -The U.S. Food and Drug Administration (FDA) has approved the granule formulation of Neurocrine Biosciences' Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on Tu...

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q4 2023 Earnings Call Transcript

Apellis Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.73 EPS, expectations were $-0.66. Apellis Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2023 Earnings Call Transcript

Rhythm Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.7 EPS, expectations were $-0.7. Rhythm Pharmaceuticals, Inc.

Biogen (BIIB) Q4 2023 Earnings Call Transcript

BIIB earnings call for the period ending December 31, 2023.

Biogen (BIIB) Q4 2023 Earnings Call Transcript

BIIB earnings call for the period ending December 31, 2023.

Vertex Pharmaceuticals (VRTX) Q4 2023 Earnings Call Transcript

VRTX earnings call for the period ending December 31, 2023.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q4 2023 Earnings Call Transcript

Operator: Good day, and welcome to the Vertex Pharmaceuticals Fourth Quarter 2023 Earnings Call. All participants will be in a listen-only mode.